Found: 13
Select item for more details and to access through your institution.
With regard to the original article "A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma".
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 434, doi. 10.1111/1759-7714.15223
- By:
- Publication type:
- Article
Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 402, doi. 10.1111/1759-7714.15210
- By:
- Publication type:
- Article
Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 419, doi. 10.1111/1759-7714.15209
- By:
- Publication type:
- Article
A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 427, doi. 10.1111/1759-7714.15208
- By:
- Publication type:
- Article
Real‐world survival outcomes of immunotherapy for advanced non‐small cell lung cancer: A single‐center retrospective review.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 394, doi. 10.1111/1759-7714.15205
- By:
- Publication type:
- Article
A case of inflammatory myofibroblastic tumor harboring EML4‐ALK fusion with a brain metastasis responding to alectinib.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 415, doi. 10.1111/1759-7714.15203
- By:
- Publication type:
- Article
Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 386, doi. 10.1111/1759-7714.15202
- By:
- Publication type:
- Article
Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 379, doi. 10.1111/1759-7714.15201
- By:
- Publication type:
- Article
Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 369, doi. 10.1111/1759-7714.15200
- By:
- Publication type:
- Article
Value of CT‐based radiomics in evaluating the response of bone metastases to systemic drug therapy in breast cancer patients.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 361, doi. 10.1111/1759-7714.15199
- By:
- Publication type:
- Article
Difficulty differentiating primary mediastinal classical Hodgkin lymphoma from inflammatory myofibroblastic tumor: A case report.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 410, doi. 10.1111/1759-7714.15197
- By:
- Publication type:
- Article
Correction to "Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway".
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 436, doi. 10.1111/1759-7714.15195
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 359, doi. 10.1111/1759-7714.14948
- Publication type:
- Article